Johns Hopkins Psychedelic Research Center
@jhpsychedelics.bsky.social
The Center for Psychedelic and Consciousness Research studies how psychedelics affect behavior, mood, cognition, brain function, & biological markers of health.
hopkinspsychedelic.org
hopkinspsychedelic.org
Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based education on how they work & who they may help.Perfect for clinicians, students, researchers, or anyone wanting reliable info in a rapidly growing field. Enroll below👇
November 20, 2025 at 9:41 PM
Curious about psychedelics beyond the hype? Our new Coursera course, Psychedelic Science and Medicine, offers clear, evidence-based education on how they work & who they may help.Perfect for clinicians, students, researchers, or anyone wanting reliable info in a rapidly growing field. Enroll below👇
CPCR Faculty
@existwell.bsky.social
will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Wednesday 11/19 at 6pm 11 E. 33rd St
@existwell.bsky.social
will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Wednesday 11/19 at 6pm 11 E. 33rd St
November 18, 2025 at 5:09 PM
CPCR Faculty
@existwell.bsky.social
will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Wednesday 11/19 at 6pm 11 E. 33rd St
@existwell.bsky.social
will give a talk on his book, which is now out on paperback, in Baltimore near Johns Hopkins campus. Open to the public! Wednesday 11/19 at 6pm 11 E. 33rd St
Dr. Boris Heifets @theborislab.bsky.social closed the conference by urging stronger cross-species feedback. Back-translating human drug effects exposes unexpected mechanisms, refines animal models, and shows why natural variability and larger studies are essential.
November 17, 2025 at 5:05 PM
Dr. Boris Heifets @theborislab.bsky.social closed the conference by urging stronger cross-species feedback. Back-translating human drug effects exposes unexpected mechanisms, refines animal models, and shows why natural variability and larger studies are essential.
Dr. Torben Ott @torbenott.bsky.social demonstrated rodent behavioral and neural models of hallucination-like percepts, emphasizing computational characterization as a powerful way to align measures across species
November 17, 2025 at 5:05 PM
Dr. Torben Ott @torbenott.bsky.social demonstrated rodent behavioral and neural models of hallucination-like percepts, emphasizing computational characterization as a powerful way to align measures across species
Dr. Katharina Schmack @kathaschmack.bsky.social opened the afternoon session with her team’s rodent model of hallucination-like percepts, a tool advancing our understanding of hallucinogenesis and pointing toward more targeted antipsychotics.
November 17, 2025 at 5:05 PM
Dr. Katharina Schmack @kathaschmack.bsky.social opened the afternoon session with her team’s rodent model of hallucination-like percepts, a tool advancing our understanding of hallucinogenesis and pointing toward more targeted antipsychotics.
Dr. Bita Moghaddam @bita137.bsky.social argued that clinically relevant cognitive processes can be modeled in animals and urged human and animal psychedelic researchers to align constructs, measures, and tasks using cognitive neuroscience tools.
November 17, 2025 at 5:05 PM
Dr. Bita Moghaddam @bita137.bsky.social argued that clinically relevant cognitive processes can be modeled in animals and urged human and animal psychedelic researchers to align constructs, measures, and tasks using cognitive neuroscience tools.
Dr. Pierre Blier traced his decades of moving between human and animal studies to uncover ketamine’s antidepressant mechanisms. His cross-species work helped reveal AMPA throughput as key, paving the way for trials targeting this pathway.
November 17, 2025 at 5:05 PM
Dr. Pierre Blier traced his decades of moving between human and animal studies to uncover ketamine’s antidepressant mechanisms. His cross-species work helped reveal AMPA throughput as key, paving the way for trials targeting this pathway.
Dr. Mark Geyer kicked off our conference, highlighting the two-way street of translational science: developing non-verbal human measures that parallel animal studies.
November 17, 2025 at 5:05 PM
Dr. Mark Geyer kicked off our conference, highlighting the two-way street of translational science: developing non-verbal human measures that parallel animal studies.
Over the weekend, CPCR hosted a satellite event to the 2025 @sfn.org conference. Researchers around the world gathered to discuss the latest advances in psychedelic neuroscience—sharing successes and challenges of translational models and exploring strategies to bridge preclinical and clinical work.
November 17, 2025 at 5:05 PM
Over the weekend, CPCR hosted a satellite event to the 2025 @sfn.org conference. Researchers around the world gathered to discuss the latest advances in psychedelic neuroscience—sharing successes and challenges of translational models and exploring strategies to bridge preclinical and clinical work.
CPCR Medical Director, Dr. Sandeep Nayak spoke on a panel yesterday with Jada Pinket Smith at the Not Alone Summit in Las Vegas, discussing psychedelics and mental health
November 12, 2025 at 4:07 PM
CPCR Medical Director, Dr. Sandeep Nayak spoke on a panel yesterday with Jada Pinket Smith at the Not Alone Summit in Las Vegas, discussing psychedelics and mental health
Dr. David Yaden will be speaking at MGH’s Psychedelics & Psychedelic Medicine Conference (Nov 14–15, virtual). Learn the latest research + earn CME/CE. Use code NET50 to save $50.
Register: lms.mghcme.org/VirtualPsych...
Register: lms.mghcme.org/VirtualPsych...
November 6, 2025 at 9:49 PM
Dr. David Yaden will be speaking at MGH’s Psychedelics & Psychedelic Medicine Conference (Nov 14–15, virtual). Learn the latest research + earn CME/CE. Use code NET50 to save $50.
Register: lms.mghcme.org/VirtualPsych...
Register: lms.mghcme.org/VirtualPsych...
Last week, Drs. Weiss and Yaden joined a Humanities on the Hill panel after the film In Waves and War, discussing the impact of war on Veterans and the promise of psychedelic therapies, alongside Marcus Capone, Paul Shenk, and Dr. Virginia Jewiss.
November 4, 2025 at 6:51 PM
Last week, Drs. Weiss and Yaden joined a Humanities on the Hill panel after the film In Waves and War, discussing the impact of war on Veterans and the promise of psychedelic therapies, alongside Marcus Capone, Paul Shenk, and Dr. Virginia Jewiss.
‼️Healthy Volunteers Needed‼️
Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing).
Apply or learn more: tinyurl.com/34jnz3d5
☎️ 410-550-2253 | ✉️ [email protected]
Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing).
Apply or learn more: tinyurl.com/34jnz3d5
☎️ 410-550-2253 | ✉️ [email protected]
November 3, 2025 at 7:26 PM
‼️Healthy Volunteers Needed‼️
Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing).
Apply or learn more: tinyurl.com/34jnz3d5
☎️ 410-550-2253 | ✉️ [email protected]
Join our Johns Hopkins study on how psilocybin affects the brain using safe, noninvasive methods (EEG, fMRI, TMS, cognitive testing).
Apply or learn more: tinyurl.com/34jnz3d5
☎️ 410-550-2253 | ✉️ [email protected]
Dr. Fred Barrett presented preliminary data on psilocybin’s efficacy for treating depression with co-occurring alcohol use disorder and its underlying therapeutic mechanisms at the 38th annual ECNP Congress in Amsterdam.
October 21, 2025 at 4:21 PM
Dr. Fred Barrett presented preliminary data on psilocybin’s efficacy for treating depression with co-occurring alcohol use disorder and its underlying therapeutic mechanisms at the 38th annual ECNP Congress in Amsterdam.
Welcome our new postdoctoral research fellow, Dr. Eddie Jacobs. Dr. Jacobs comes to us from Oxford where he investigated ethical aspects of psychedelic therapies. At the CPCR, his work will explore how pre-existing worldviews & beliefs influence the quality and character of psychedelic experiences
October 13, 2025 at 5:17 PM
Welcome our new postdoctoral research fellow, Dr. Eddie Jacobs. Dr. Jacobs comes to us from Oxford where he investigated ethical aspects of psychedelic therapies. At the CPCR, his work will explore how pre-existing worldviews & beliefs influence the quality and character of psychedelic experiences
🌿 Can psychedelics help with long-COVID & Lyme?
Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event!
🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg
#CPCR #PsychedelicResearch #LongCOVID #LymeDisease
Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event!
🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg
#CPCR #PsychedelicResearch #LongCOVID #LymeDisease
September 24, 2025 at 7:53 PM
🌿 Can psychedelics help with long-COVID & Lyme?
Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event!
🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg
#CPCR #PsychedelicResearch #LongCOVID #LymeDisease
Join Dr. Albert Garcia-Romeu (JHU) + an expert panel as they share new research & lived experiences. Free online event!
🔗https://us02web.zoom.us/meeting/register/vg5di-PqS6Ko-GOFOL4Ljg
#CPCR #PsychedelicResearch #LongCOVID #LymeDisease
Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply below 👇
jobs.jhu.edu/job/Baltimor...
jobs.jhu.edu/job/Baltimor...
September 16, 2025 at 6:39 PM
Our research center is seeking a casual therapist to support cutting-edge studies on the therapeutic effects of psychedelics. Join a team at the forefront of mental health research. Apply below 👇
jobs.jhu.edu/job/Baltimor...
jobs.jhu.edu/job/Baltimor...
CPCR Faculty David Yaden (@existwell) visited the Uehiro Oxford Institute at Oxford University, advancing work on well-being and the ethics of psychedelics.
September 15, 2025 at 4:03 PM
CPCR Faculty David Yaden (@existwell) visited the Uehiro Oxford Institute at Oxford University, advancing work on well-being and the ethics of psychedelics.
Missed our summer newsletter?
Catch up on the latest updates from the CPCR and subscribe to stay in the loop:
🔗 hopkinspsychedelic.org/newsletters
Catch up on the latest updates from the CPCR and subscribe to stay in the loop:
🔗 hopkinspsychedelic.org/newsletters
September 10, 2025 at 3:29 PM
Missed our summer newsletter?
Catch up on the latest updates from the CPCR and subscribe to stay in the loop:
🔗 hopkinspsychedelic.org/newsletters
Catch up on the latest updates from the CPCR and subscribe to stay in the loop:
🔗 hopkinspsychedelic.org/newsletters
New study from Dr. Brandon Weiss (CPCR) finds UK public attitudes toward psychedelic-assisted therapy are mostly neutral with a slight negative tilt. Published in the International Journal of Drug Policy
September 8, 2025 at 3:04 PM
New study from Dr. Brandon Weiss (CPCR) finds UK public attitudes toward psychedelic-assisted therapy are mostly neutral with a slight negative tilt. Published in the International Journal of Drug Policy
Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann...
Your responses help advance research on their effects, risks, and benefits.
Your responses help advance research on their effects, risks, and benefits.
September 5, 2025 at 6:41 PM
Have you used psychedelics and cannabis on separate occasions? Take our survey! tinyurl.com/psyches-cann...
Your responses help advance research on their effects, risks, and benefits.
Your responses help advance research on their effects, risks, and benefits.
Former CPCR postdoc Dr. Jérémie Richard has joined the University of Ottawa as an Assistant Professor in the School of Psychology. He will teach graduate courses in Clinical Psychology and Psychedelic Studies while advancing research on psychedelics and health. Congratulations, Dr. Richard! 🎉
August 22, 2025 at 5:02 PM
Former CPCR postdoc Dr. Jérémie Richard has joined the University of Ottawa as an Assistant Professor in the School of Psychology. He will teach graduate courses in Clinical Psychology and Psychedelic Studies while advancing research on psychedelics and health. Congratulations, Dr. Richard! 🎉
Join us for a webinar with Dr. Albert Garcia-Romeu, presenting on Wednesday, August 20th from 12–1 PM PT, hosted by the USC Institute for Addiction Science in Los Angeles, CA.
📍 Registration is required: us02web.zoom.us/webinar/regi...
📍 Registration is required: us02web.zoom.us/webinar/regi...
August 19, 2025 at 4:54 PM
Join us for a webinar with Dr. Albert Garcia-Romeu, presenting on Wednesday, August 20th from 12–1 PM PT, hosted by the USC Institute for Addiction Science in Los Angeles, CA.
📍 Registration is required: us02web.zoom.us/webinar/regi...
📍 Registration is required: us02web.zoom.us/webinar/regi...
The Johns Hopkins Center for Psychedelic and Consciousness Research is committed to public education. Join for Understanding Psychedelic Experiences with Dr. David Yaden at Profs and Pints in Baltimore, MD.
📅 Tue, Aug 19 at 6 PM
📍 The Perch, 1110 S Charles St
🎟️ $13.50 adv | $17 door ($15 student)
📅 Tue, Aug 19 at 6 PM
📍 The Perch, 1110 S Charles St
🎟️ $13.50 adv | $17 door ($15 student)
August 18, 2025 at 5:14 PM
The Johns Hopkins Center for Psychedelic and Consciousness Research is committed to public education. Join for Understanding Psychedelic Experiences with Dr. David Yaden at Profs and Pints in Baltimore, MD.
📅 Tue, Aug 19 at 6 PM
📍 The Perch, 1110 S Charles St
🎟️ $13.50 adv | $17 door ($15 student)
📅 Tue, Aug 19 at 6 PM
📍 The Perch, 1110 S Charles St
🎟️ $13.50 adv | $17 door ($15 student)
📢 Now Recruiting: Research Study on Psilocybin for Depression in Early Alzheimer’s Disease: Psilocybin for depression in early Alzheimer’s/MCI. Receive treatment & free counseling in a safe setting. Sign up: hopkinspsychedelic.org/alzheimers
August 12, 2025 at 3:30 PM
📢 Now Recruiting: Research Study on Psilocybin for Depression in Early Alzheimer’s Disease: Psilocybin for depression in early Alzheimer’s/MCI. Receive treatment & free counseling in a safe setting. Sign up: hopkinspsychedelic.org/alzheimers